Virtu Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82K | Buy |
+39,593
| New | +$82K | ﹤0.01% | 1062 |
|
|
2024
Q3 | – | Sell |
-40,165
| Closed | -$141K | – | 1583 |
|
|
2024
Q2 | $141K | Buy |
+40,165
| New | +$141K | 0.01% | 782 |
|
|
2024
Q1 | – | Sell |
-41,237
| Closed | -$70K | – | 1694 |
|
|
2023
Q4 | $70K | Buy |
41,237
+25,608
| +164% | +$43.5K | 0.01% | 1112 |
|
|
2023
Q3 | $16K | Buy |
+15,629
| New | +$16K | ﹤0.01% | 1043 |
|
|
2022
Q3 | – | Sell |
-67,900
| Closed | -$189K | – | 1923 |
|
|
2022
Q2 | $189K | Buy |
67,900
+24,331
| +56% | +$67.7K | 0.02% | 772 |
|
|
2022
Q1 | $249K | Buy |
43,569
+25,263
| +138% | +$144K | 0.02% | 671 |
|
|
2021
Q4 | $167K | Buy |
+18,306
| New | +$167K | 0.02% | 905 |
|
|
2021
Q1 | – | Sell |
-20,667
| Closed | -$437K | – | 1787 |
|
|
2020
Q4 | $437K | Buy |
+20,667
| New | +$437K | 0.05% | 478 |
|
|
2020
Q3 | – | Sell |
-39,131
| Closed | -$576K | – | 1268 |
|
|
2020
Q2 | $576K | Buy |
+39,131
| New | +$576K | 0.07% | 332 |
|
|
2019
Q4 | $410K | Buy |
+17,460
| New | +$410K | 0.04% | 508 |
|
|
2018
Q4 | – | Sell |
-27,454
| Closed | -$869K | – | 1722 |
|
|
2018
Q3 | $869K | Buy |
27,454
+17,873
| +187% | +$566K | 0.05% | 378 |
|
|
2018
Q2 | $372K | Buy |
9,581
+7
| +0.1% | +$272 | 0.02% | 992 |
|
|
2018
Q1 | $264K | Sell |
9,574
-43,515
| -82% | -$1.2M | 0.01% | 1148 |
|
|
2017
Q4 | $961K | Buy |
53,089
+21,495
| +68% | +$389K | 0.05% | 453 |
|
|
2017
Q3 | $510K | Buy |
+31,594
| New | +$510K | 0.03% | 918 |
|